Market Overview:
The global endocrinology hormones reagents market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of endocrine disorders, rising demand for precision medicine, and technological advancements in the field of endocrinology. Based on type, the follicle-stimulating hormone (FSH) segment is expected to account for the largest share of the global endocrinology hormones reagents market in 2018. This segment is anticipated to grow at a CAGR of 7% during the forecast period. FSH plays an important role in regulating ovarian function and fertility. It is also used as a marker for assessing ovarian reserve and response to ovulation induction therapy.
Product Definition:
Endocrinology is the study of hormones and their interactions with cells and tissues. Hormones are important for regulating metabolism, growth, development, and reproduction. Reagents are used in endocrinology to measure hormone levels in blood or other body fluids.
Follicle-stimulating Hormone:
Follicle-stimulating hormone (FSH) is a glycoprotein hormone produced by the anterior pituitary gland in response to stimulation of the Follicle Stimulating Gland (FSG). It is important for growth and development of cells in the thyroid, ovary, and adrenal glands.
Luteinizing Hormone:
Luteinizing hormone (LH) is a glycoprotein released by the pituitary gland in response to stimulation of the ovary. It acts on the target cells to trigger the production of vitamin A and allows for vision correction, cell growth & differentiation, and proper body functioning.
Application Insights:
The scientific research segment dominated the global endocrinology hormones reagents market in 2017. This is owing to a rise in R&D activities pertaining to the development of new diagnostics and therapeutics for various endocrine disorders. In addition, an increase in government funding for research related to hormones has also positively influenced the growth of this segment.
Hospital application is expected to witness significant growth over the forecast period due largely on a rise in prevalence of chronic diseases such as diabetes and cancer that require regular monitoring and treatment with hormone therapy drugs.
Regional Analysis:
North America dominated the global endocrinology hormones reagents market in 2017. The presence of key players, advanced healthcare infrastructure and high prevalence of target diseases are some factors responsible for its large share. In addition, increasing R&D activities to develop novel products is expected to drive the regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare facilities in emerging countries such as China and India.
In 2016, Japan was one of largest markets for these products due to a rise in aging population with various associated disorders such as diabetes & obesity (insulin resistance), osteoporosis (men), breast cancer (women) 9 which require long-term hormone replacement therapy 10 or other endocrine therapies 11 .
Growth Factors:
- Increasing incidence of endocrine disorders: The global incidence of endocrine disorders is increasing at a rapid pace. This is primarily attributed to the changing lifestyle and dietary habits. This, in turn, is fueling the demand for endocrinology hormones reagents.
- Growing awareness about endocrine disorders: There is a growing awareness among people about the various types of endocrine disorders and their symptoms. This is helping to create a larger pool of potential patients for treatment with endocrinology hormones reagents.
- Technological advancements in hormone testing: There have been significant advancements in technology for hormone testing in recent years. This has helped to improve the accuracy and precision of hormone tests, thus driving demand for Endocrinology Hormones Reagents market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Endocrinology Hormones Reagents Market Research Report
By Type
Follicle-stimulating Hormone, Luteinizing Hormone, Progesterone, Growth Hormone, Others
By Application
Hospital, Scientific Research
By Companies
Roche, BCI, Siemens, Abbott, Tosoh, Snibe Diagnostic, Adaltis, Wantai BioPharm, Biocell, EasyDiagnosis Biomedicine, DRG International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Endocrinology Hormones Reagents Market Report Segments:
The global Endocrinology Hormones Reagents market is segmented on the basis of:
Types
Follicle-stimulating Hormone, Luteinizing Hormone, Progesterone, Growth Hormone, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Scientific Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- BCI
- Siemens
- Abbott
- Tosoh
- Snibe Diagnostic
- Adaltis
- Wantai BioPharm
- Biocell
- EasyDiagnosis Biomedicine
- DRG International
Highlights of The Endocrinology Hormones Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Follicle-stimulating Hormone
- Luteinizing Hormone
- Progesterone
- Growth Hormone
- Others
- By Application:
- Hospital
- Scientific Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endocrinology Hormones Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Endocrinology hormones reagents are chemicals that are used to study the effects of hormones on cells and tissues.
Some of the major companies in the endocrinology hormones reagents market are Roche, BCI, Siemens, Abbott, Tosoh, Snibe Diagnostic, Adaltis, Wantai BioPharm, Biocell, EasyDiagnosis Biomedicine, DRG International.
The endocrinology hormones reagents market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endocrinology Hormones Reagents Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Endocrinology Hormones Reagents Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Endocrinology Hormones Reagents Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Endocrinology Hormones Reagents Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Endocrinology Hormones Reagents Market Size & Forecast, 2020-2028 4.5.1 Endocrinology Hormones Reagents Market Size and Y-o-Y Growth 4.5.2 Endocrinology Hormones Reagents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Follicle-stimulating Hormone
5.2.2 Luteinizing Hormone
5.2.3 Progesterone
5.2.4 Growth Hormone
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Scientific Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endocrinology Hormones Reagents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endocrinology Hormones Reagents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Follicle-stimulating Hormone
9.6.2 Luteinizing Hormone
9.6.3 Progesterone
9.6.4 Growth Hormone
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Scientific Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Follicle-stimulating Hormone
10.6.2 Luteinizing Hormone
10.6.3 Progesterone
10.6.4 Growth Hormone
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Scientific Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Follicle-stimulating Hormone
11.6.2 Luteinizing Hormone
11.6.3 Progesterone
11.6.4 Growth Hormone
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Scientific Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Follicle-stimulating Hormone
12.6.2 Luteinizing Hormone
12.6.3 Progesterone
12.6.4 Growth Hormone
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Scientific Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Follicle-stimulating Hormone
13.6.2 Luteinizing Hormone
13.6.3 Progesterone
13.6.4 Growth Hormone
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Scientific Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endocrinology Hormones Reagents Market: Competitive Dashboard
14.2 Global Endocrinology Hormones Reagents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 BCI
14.3.3 Siemens
14.3.4 Abbott
14.3.5 Tosoh
14.3.6 Snibe Diagnostic
14.3.7 Adaltis
14.3.8 Wantai BioPharm
14.3.9 Biocell
14.3.10 EasyDiagnosis Biomedicine
14.3.11 DRG International